INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

InfuSystem Holdings, Inc

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026

$13.74+0.34 (+2.54%)

Close on Oct 19, 2026

Market cap: $287.44M
P/E (TTM): 33.5
Dividend yield: –

InfuSystem Holdings, Inc income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Revenue	143	135	126	110	102	97	81	67	71	70	71	66	62	59	55	47	39
Cost of Revenue	63	64	63	49	44	39	34	28	18	16	14	12	11	9.17	9.13	7.73	6.20
Gross Profit	80	70	63	61	59	59	47	40	43	45	50	47	44	43	35	34	29
Selling, General & Admin	67	63	58	56	51	45	39	35	35	34	34	30	29	33	27	28	17
Selling & Marketing	10	11	13	12	11	9.66	9.93	9.11	9.78	9.66	10	9.75	9.66	9.86	9.37	7.09	5.26
General & Administrative	57	51	45	44	41	35	29	25	25	25	24	20	19	23	18	21	12
Operating Expenses	68	64	59	59	56	50	43	39	47	44	42	38	38	41	102	34	23
Operating Income	12	6.89	4.09	1.65	2.82	8.83	3.53	0.42	-3.81	0.97	7.28	9.33	5.90	2.00	-66	-0.94	5.33
Interest Expense	1.30	1.78	2.17	1.40	1.38	1.26	1.90	1.42	1.33	1.34	1.71	3.13	3.50	3.34	2.19	3.35	3.50
Other Non-Operating Income	0.00	-0.06	-0.07	-0.12	-0.19	-0.03	-0.10	-0.04	-1.45	-1.34	-3.29	-3.12	-3.20	-4.15	-2.22	-2.29	-3.58
Asset Impairment Charges	–	–	–	–	–	0	0	0	0.99	0	0.59	0.28	-0.05	0.24	68	–	–
Gain (Loss) on Sale of Assets	3.31	2.27	2.89	2.18	2.55	3.58	1.45	1.34	1.66	1.23	2.44	2.18	2.03	1.96	2.75	–	–
Pretax Income	11	5.06	1.85	0.13	1.26	7.54	1.52	-1.04	-5.26	-0.36	3.99	6.21	2.70	-2.15	-69	-3.22	1.75
Income Tax Expense	4.00	2.71	0.98	0.11	-0.16	-9.79	0.16	0.05	15	-0.14	1.20	2.85	1.03	-0.66	-23	-1.37	0.98
Net Income	6.63	2.35	0.87	0.02	1.42	17	1.36	-1.10	-21	-0.22	2.79	3.36	1.67	-1.49	-45	-1.85	0.77
EPS (Basic)(per share)	0.32	0.11	0.04	0.00	0.07	0.86	0.07	-0.05	-0.91	-0.01	0.13	0.15	0.08	-0.07	-2.16	-0.09	0.04
EPS (Diluted)(per share)	0.31	0.11	0.04	0.00	0.06	0.80	0.07	-0.05	-0.91	-0.01	0.12	0.15	0.08	-0.07	-2.16	-0.09	0.04
Shares Outstanding (Basic, Weighted)(shares)	21	21	21	21	21	20	20	21	23	23	22	22	22	21	21	20	19
Shares Outstanding (Diluted, Weighted)(shares)	21	22	22	22	22	22	21	21	23	23	23	23	22	21	21	20	19
EBITDA	25	19	17	15	17	23	16	12	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 57.5%
Operating margin: 9.3%
Net margin: 6.0%
Return on equity, FY2025: 11.5%

Financial strength

Current ratio: 2.50
Debt to equity: 0.35
Debt to assets: 20.9%
Cash to current liabilities: 6.3%

Valuation

P/E ratio: 33.5
Price to sales: 2.01
Price to book: 4.86
Dividend yield: –